Form D · Pharmaceuticals

AKORN INC

Lake Forest, IL · CIK 0000003116

Offering snapshot reported Apr 29, 2009 · SEC filing

Reported sold
$0
Offering amount: $1.67M
Investors reported
Not reported
Form D · investor count
Minimum accepted
Not reported
Reported outside-investor minimum
First sale
Not reported
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 29, 2009Initial$0No comparisonNot reportedSEC filing
Apr 29, 2009Initial$0No comparisonNot reportedSEC filing
Nov 26, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Oct 10, 2006PaperNot reportedNo comparisonNot reportedSEC filing
Mar 17, 2006PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Not reported
Exemptions
Not reported
Duration over one year
Not reported
Business combination
Not reported
Sales commissions
Not reported
Finders' fees
Not reported
Form D file number
021-16405-A

Source: Form D, filed Apr 29, 2009. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Abu, Ph.D Alam Executive
Sam, Ph.D Boddapati Executive
Jerry N. Ellis Director
Ronald M. Johnson Director
Subhash Kapre Director
John R. Sabat Executive
Neill Shanahan Executive
Mark Silverberg Executive
Michael P. Stehn Executive
Jerry I. Treppel Director
Randall Wall Director
Jeffrey A. Whitnell Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
1925 W. Field Court, Suite 300
Lake Forest, IL, 60045